rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Douglas J. Seith

Chief Operating Officer

Company insider

Files Form 4 as: Chief Operating Officer, AtriCure.

Every Form 4 they filed

In numbers

Trades disclosed
126
Buys
2
Sells
15
Bought
$111K
Sold
$11.9M
Companies
1
Companies where not an officer
0
First trade
20 May 2013
Last trade
30 Jun 2026
Last filed
2 Jul 2026

Companies traded

Where they are an officer
ATRC AtriCureOfficer · Medical Devices · last 30 Jun 20262 buys · 15 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Jun 2026filed 2 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A$13K527 at $23.78filing
30 Jun 2026filed 2 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A$13K527 at $23.78filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—42,386 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—25,532 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code F$717K22,948 at $31.26filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—42,386 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—25,532 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code F$717K22,948 at $31.26filing
31 Dec 2025filed 2 Jan 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A$7,034257 at $27.37filing
31 Dec 2025filed 2 Jan 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A$7,034257 at $27.37filing
30 Jun 2025filed 2 Jul 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A$14K550 at $25.84filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A—32,266 at $0.00filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A—12,120 at $0.00filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code F$583K15,050 at $38.74filing
28 Jun 2024filed 2 Jul 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code A$14K707 at $19.35filing
1 Mar 2024filed 5 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code A—37,899 at $0.00filing
1 Mar 2024filed 5 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code A—19,205 at $0.00filing
1 Mar 2024filed 5 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code F$530K14,596 at $36.28filing
30 Jun 2023filed 3 Jul 2023ATRC AtriCureMedical DevicesSEC FORM 4 Code A$21K557 at $38.11filing
1 Mar 2023filed 3 Mar 2023ATRC AtriCureMedical DevicesSEC FORM 4 Code A—15,453 at $0.00filing

News

Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026

0 headlines in the last 90 days name Douglas J. Seith; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care17

Buys in green, sells in red, by the company’s sector.

Related people

Salvatore PriviteraChief Technical Officer · Chief Technical Officer at AtriCure, filing Form 4 there in the last year
Regina E. GrovesDirector · Director at AtriCure, filing Form 4 there in the last year
Karl S. DahlquistChief Legal Officer · Chief Legal Officer at AtriCure, filing Form 4 there in the last year
Karen PrangeDirector · Director at AtriCure, filing Form 4 there in the last year
Maggie YuenDirector · Director at AtriCure, filing Form 4 there in the last year
Gilbert Ray Cisneros, Jr.Representative, CA-31 · Also traded ATRC in the last 90 days
Justin J. NozneskyChief Mktg & Strategy Officer · Also traded ATRC in the last 90 days
Sven WehrweinDirector · Also traded ATRC in the last 90 days